RAAS inhibitors in MASLD are linked to reduced liver cancer risk in a Taiwan study. Learn more about the findings and clinical implications.

Please provide your email address to receive an email when new articles are posted on . In June 2023, 74% of respondents from a multinational, multisociety Delphi process agreed that the term ...

BOSTON -- A mathematical model predicts that the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) -- formerly known as nonalcoholic fatty liver disease (NAFLD) -- will ...

Please provide your email address to receive an email when new articles are posted on . In a cross-sectional analysis of adults who attended outpatient clinics at the University of Florida in ...

The prevalence rate for lean MASLD varies widely, from 3.8% to 34.1%, according to the literature reviewed in this study. Lifestyle modifications in lean patients, including reducing body weight by 3% ...

More than 11% of US adolescents had suspected metabolic dysfunction–associated steatotic liver disease (MASLD), and 77.2% with elevated alanine aminotransferase (ALT) levels met the criteria for ...

Does Fatty Liver Lead to Cirrhosis ? Fatty liver disease, now called steatotic liver disease, happens when too much fat builds up in your liver. Over time, this extra fat can cause inflammation and ...

Credit: Getty Images Our easy-to-read fact sheet provides an overview of the relationship between metabolic dysfunction-associated steatotic liver disease and obesity. Our easy-to-read fact sheets ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a more advanced form of metabolic dysfunction-associated steatotic liver disease (MASLD). It happens when fat buildup progresses to ...

Trial liver safety data from the ‘ESSENCE’ trial confirm semaglutide's favourable hepatic profile in patients with Metabolic ...